Complix
Mark Vaeck is the current CEO and Director at Complix. Mark has also served as the chief executive officer at actogenix n.v., interna, and ablynx nv. In addition, they were the chief operations officer at Ceres. Mark has over 20 years of experience in the biotech industry.
A direct report to Mark Vaeck is and Ignace Lasters - CTO.
Complix
Complix is a biopharmaceutical company developing Alphabodies, a novel class of biopharmaceuticals.